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Abstract: 
 
Background: Globally pollen allergy is a major public health problem, but a fundamental 
unknown is the likely impact of climate change. To our knowledge, this is the first study to 
quantify the consequences of climate change upon pollen allergy in humans. 
Objectives: To produce quantitative estimates of the potential impact of climate change upon 
pollen allergy in humans, focusing upon common ragweed (Ambrosia artemisiifolia) in Europe. 
Methods: A process-based model estimated the change in ragweed’s range under climate change. 
A second model simulated current and future ragweed pollen levels. These were translated into 
health burdens using a dose-response curve generated from a systematic review and current and 
future population data. Models considered two different suites of regional climate/pollen models, 
two greenhouse gas emissions scenarios (RCP4.5 and 8.5), and three different plant invasion 
scenarios. 
Results: Our primary estimates indicate that sensitization to ragweed will more than double in 
Europe, from 33 to 77 million people, by 2041-2060. According to our projections, while 
sensitization will increase in countries with an existing ragweed problem (e.g. Hungary, the 
Balkans), the greatest proportional increases will occur where sensitization is uncommon (e.g. 
Germany, Poland, France). Higher pollen concentrations and a longer pollen season may also 
increase the severity of symptoms. Our model projections are driven predominantly by changes 
in climate (66%), but also are influenced by current trends in the spread of this invasive plant 
species. Assumptions about the rate at which ragweed spreads throughout Europe have a large 
influence upon the results. 
Conclusions: Our quantitative estimates indicate that ragweed pollen allergy will become a 
common health problem across Europe, expanding into areas where it is currently uncommon. 
Control of ragweed spread may be an important adaptation strategy in response to climate 
change. 
  
Introduction 
Climate change is likely to affect allergic disease (Smith et al. 2014) and the view of clinical 
experts is that these diseases will increase under climate change (Bielory et al. 2012), due in part 
to the impact on allergenic plant species (Shea et al. 2008). Impacts on allergens may be one of 
the most important consequences of climate change for human health (Beggs 2015). Climate 
change has already been suggested as one factor behind the increasing prevalence of allergic 
asthma (Beggs and Bambrick 2005). Pollens are a major cause of symptoms in people with 
allergic disease, but there is no quantitative assessment of how future climate change may affect 
the levels of pollen allergy in humans, because the influence of climate change is complex (Reid 
and Gamble 2009; Smith et al. 2014). For example, an altered climate will affect the range of 
allergenic species as well as the timing and length of the pollen season, and elevated Carbon 
Dioxide (CO2) may increase plant productivity and pollen production (Beggs 2015). Climate 
change may also affect the release and atmospheric dispersion of pollen (Bielory et al. 2012). 
The overall impact will be an altered pollen season timing and load, and hence change in 
exposure. Modelling all these processes is required to assess the consequences of climate change 
on pollen-related allergic disease. Previous studies (reviewed in Bielory et al. 2012) have only 
examined some of the processes along this pathway. 
Allergic disease is a key public health problem which has increased rapidly in recent decades in 
both developed and developing countries and is now recognised as a major global epidemic 
(Pawankar 2014; Platts-Mills 2015). The economic burden of allergic disease is considerable. In 
2007, the total cost of allergic disease to the United States (US) was $19.7 billion, while in the 
European Union (EU) estimates range from €55 to €151 billion (Zuberbier et al. 2014). In terms 
of specific allergic diseases, the World Health Organisation (WHO) estimates that 400 million 
  
people in the world suffer from allergic rhinitis and 300 million from asthma (Bousquet and 
Khaltaev 2007). Within Europe the prevalence of pollen allergy in the general population is 
estimated at 40% (D'Amato et al. 2007). 
Here, we quantify the potential consequences of climate change on pollen allergy, focussing 
upon the annual herbaceous plant common ragweed (Ambrosia artemisiifolia) in Europe 
(henceforth ragweed). In Europe, ragweed is an introduced species in the middle of an ongoing 
invasion event (Storkey et al. 2014) and, therefore, represents a case of a human population 
being progressively exposed to a novel allergen. It is highly invasive; thriving on disturbed land, 
with each plant producing up to 62,000 seeds a year. Ragweed is particularly harmful for public 
health because each plant produces a large amount of pollen (up to 1 billion grains a year; 
Fumanal et al. 2007) and its allergenic potential is high (Taramarcaz et al. 2005). Unlike other 
pollen, ragweed pollen peaks in the late summer (Essl et al. 2015). In some parts of Europe, 
ragweed generates around 50% of the total pollen production. In the USA, where ragweed is 
native, over 26% of the population is sensitized to ragweed (Arbes Jr et al. 2005). This study 
focusses upon ragweed sensitization as a health consequence. Sensitization occurs when the 
human immune system has synthesised antibodies against the pollen and reacts when re-exposed, 
and is a major risk factor for allergic diseases such as allergic rhinoconjunctivitis and asthma 
(Burbach et al. 2009). 
Methods 
 
This research is the culmination of a large multidisciplinary European Commission funded 
project (ATOPICA; FP7 grant agreement #282687). Specifically, for the present analysis we 
integrate estimates of current and future ragweed pollen levels (previously developed within 
ATOPICA) with published data on sensitization rates and population density. To estimate pollen 
  
levels, the ATOPICA group first used a process-based model of weed growth, plant population 
dynamics, and competition, to project the future expansion of ragweed’s range under different 
climate change scenarios (for details see; Storkey et al. 2014). These range results were then 
inputted into a system modelling plant invasion, pollen production, pollen release, and the 
atmospheric dispersion of pollen to simulate current (1986-2005) and future (2041-2060) 
ragweed pollen levels in Europe (for details see; Hamaoui-Laguel et al. 2015). To provide an 
estimate of uncertainty, these projections were produced for two different suites of regional 
climate/pollen models (henceforth CHIMERE and WRF/RegCM; Hamaoui-Laguel et al. 2015). 
These differ in their driving global climate models, and representation of dynamical and physical 
atmospheric processes. Both model suites used CMIP5 data (Taylor et al. 2012) to account for 
changing land use patterns. In addition, pollen levels were simulated under two alternative 
greenhouse gas concentration scenarios (RCP8.5 assuming high emissions, and RCP4.5 
assuming moderate emissions) and three different ragweed plant invasion scenarios (slow, rapid, 
or reference rates of spread) (Hamaoui-Laguel et al. 2015). The outputs from these models were 
daily ragweed pollen levels for 50-km grid cells across Europe. Two estimates of current levels 
were produced (based on CHIMERE or WRF/RegCM) and twelve estimates of future levels 
(based on CHIMERE or WRF/RegCM, plus the two RCPs and three plant invasion scenarios) 
For the present analysis, these fourteen estimates of current and future ragweed pollen were 
combined with health and population data to quantify their public health significance using 
ragweed sensitization rate (RSR) as a health consequence. Sensitization to ragweed is related to 
long-term pollen exposure, thus these daily pollen outputs were aggregated to provide estimates, 
on a 50km grid, of average total season ragweed pollen. 
  
To produce quantitative estimates of the potential impact of future ragweed pollen levels on 
RSRs, we first needed to generate a dose-response curve that would be representative of 
populations in locations with varying ragweed pollen levels, and characteristics that might 
confound the association between pollen levels and RSRs. Although we considered using 
estimates from an existing multicentre study [e.g., from the ATOPICA project (ATOPICA 2014), 
the GA
2
LEN study (Heinzerling et al. 2009), or ECRHS (Bousquet et al. 2007)] none of these 
were considered suitable as they either did not sample across a wide range of ragweed pollen 
levels, focused upon a subset of the population, or were restricted to patients with existing 
allergic disease. 
 
We instead performed a systematic review of Web of Science, Medline, BIOSIS, the Cochrane 
library, OpenGrey, and Google Scholar to generate a pooled estimate of the dose-response curve 
between ragweed and RSR based on all available studies that met a clearly established set of 
criteria. We used the following major search terms as MeSH (Medical Subject Headings) and all- 
field text words, as appropriate: immunology, pollen, aeroallergen, allergy, allergens, atopy, 
sensitize (or sensitise), sensitized (or sensitised), sensitization (or sensitisation), hypersensitivity, 
skin test, and Immunoglobulin E. The initial search identified 1923 potentially relevant papers 
(Figure S1). A first filter of the search results (Table S1) retained 50 papers that included 
estimate of RSRs for human populations within Europe (RSRs for 144 locations in total). Two 
authors (MA and IL) independently screened the remaining papers and extracted the following 
study information using standardized forms: location (country, place name), time period, sample 
characteristics (number, age, and population-based or allergy patients), the reactivity marker 
used (e.g., skin prick test, specific ragweed Immunoglobulin E), and the RSR. We then further 
excluded 15 papers that did not clearly report the sensitivity to ragweed alone, that involved a 
  
highly restricted sample population (e.g., institutionalized elderly, weed-sensitive allergy patients, 
patients with symptoms restricted to the ragweed season), that were undertaken more than two 
decades ago (i.e., pre-1993), or that had a small sample size (< 50 individuals). Finally, for 
studies that reported multiple RSRs at a single location (such as a series of annual sensitization 
observations, observations over several time periods, or for more than one age cohort) we 
selected a single RSR value representing the baseline period and the general population. The 
review concluded with 66 location-specific RSRs from 35 studies and 20 European countries 
(Table S2). 
Each location-specific RSR was matched (on geographic coordinates) to modelled average total 
season ragweed pollen levels for the baseline period (1986-2005) from Hamaoui-Laguel et al. 
(2015). We then used a generalized linear model to estimate the association between the natural 
log-transformed mean pollen level (ln-mean pollen) at each location and the corresponding RSR 
for that location, adjusting for the study population type (general population, i.e., a random 
sample of individuals, or atopic population, e.g., allergy clinic patients). Although we considered 
adjusting for other factors known to affect RSR (e.g. skin prick test vs. allergen-specific IgE, 
atopic characteristics, and population characteristics such as age and gender), relevant data were 
often missing. The final model included 63 location-specific RSRs, after excluding 3 locations 
with very low baseline pollen levels (< 10 grains m
3
y
-1
). The resulting model coefficient for ln- 
 
mean pollen was 5.85 (SE 1.10, p-value <0.001; 95% confidence interval 3.66, 8.04) with an 
adjusted R
2 
= 0.384. The coefficient for study type (atopic versus general population) was 9.35 
(SE 3.70, p-value 0.014; 95% confidence interval 1.94, 16.76). A plot of the association between 
mean pollen counts and RSR, adjusted for study population type, is presented in Figure 1. 
  
We then used the model coefficient and the estimated ln-mean pollen count in each 50-km grid 
cell to estimate an RSR for each grid cell. This was performed on our two current and twelve 
future estimates of ragweed pollen across Europe. To estimate the absolute numbers of sensitized 
individuals we combined the gridded RSR data with NUTS3 boundaries (subdivisions of the 28 
EU countries into regions of 150-800k residents) and population data, to estimate the number of 
sensitized individuals at the NUTS3 level. These data were aggregated to the NUTS2 level 
(regions with 0.8–3 million residents) as many NUTS3 areas are smaller in size than the 50 km 
grid cells. NUTS data were sourced from the Statistical Office of the European Union [Eurostat]. 
For 12 non-EU European countries we used boundaries and population data from the Global 
Administrative Areas database (DIVA-GIS 2015). Projections of population change were 
obtained from the World Bank databank (Table S4; World Bank 2015) and applied equally to all 
NUTS2 areas within a country, to estimate population counts in 2041-2060. 
Burbach et al. (2009) indicated that only a proportion of patients sensitized to ragweed 
experience symptoms, and presented estimates of clinically relevant sensitization rates for 
ragweed in different European countries. These estimates were obtained and applied at the 
country level to the numbers of ragweed sensitized individuals. 
To estimate changes in the severity of ragweed allergy symptoms for sensitized individuals, and 
the time period over which they are experienced, we additionally generated monthly maps of 
estimated ragweed pollen counts over the pollen season. 
Results 
 
The pollen RSR dose-response function was applied to the 14 ragweed pollen maps on a 50km 
grid, and the corresponding population sensitized to ragweed at the NUTS2 level was mapped 
  
and tabulated at the European and country level. Initially focusing upon the reference plant 
invasion scenario, six RSR maps and country level data on the sensitized population were 
produced (2 current + 4 future). These differed according to the regional climate/pollen model 
(CHIMERE or WRF/RegCM), time period (baseline or future) and RCP scenario used. These 
maps are presented in Figure S2 and Table S3. Estimates of the sensitized population based on 
airborne pollen levels generated using the WRF/RegCM model suite were 27-39% higher than 
corresponding estimates based on the CHIMERE model suite for both the baseline period and the 
future period. A comparison of the spatial patterns of current and future sensitization indicated 
that these model divergences were greatest in North and Western Europe (Germany, Belgium, 
Netherlands and France) with WRF/RegCM indicating a greater sensitized population due to the 
higher levels of pollen there. These results also indicated that the choice of RCP scenario makes 
little difference to the results by 2041-2060, irrespective of model suite; the sensitized 
populations differed by only around 5%. To provide an indication of the uncertainty, Table S3 
also provides 95% confidence intervals based upon the pollen RSR dose response relationship. 
These indicate that there is relatively large uncertainty regarding the current and future sensitized 
population, a consequence of the divergent studies presented in Figure 1. 
 
 
The two model suites are here considered to be equally plausible, as they both show a similar 
performance in simulating pollen amounts compared to limited available observations (Hamaoui- 
Laguel et al. 2015). Therefore, the estimated population affected was averaged across the two 
model suites for all further analysis. However, in the numerical results the data for both model 
suites are additionally reported in square brackets [CHIMERE, WRF/RegCM] as an indicator of 
uncertainty. All subsequent results are presented for RCP4.5 (i.e., a moderate degree of climate 
  
change) for the sake of simplicity, bearing in mind that the numbers of sensitized individuals in 
the future are very similar between RCP4.5 and RCP8.5. 
 
 
Our best estimates of the current and future population sensitized to ragweed from the pollen 
RSR dose response relationship of Figure 1 are presented in Figure 2. The sensitized population 
numbers are presented in Table 1 at the country level and summed for EU28, non EU28 and for 
Europe as a whole. Overall, our estimates indicate that under the RCP4.5 emissions scenario and 
the reference ragweed invasion scenario, the number of people sensitized to ragweed in Europe 
increases from approximately 33 million [27m – 38m based on CHIMERE and WRF/RegCM, 
respectively] at baseline to 77 million [68m – 86m] in 2041-2060 due to higher pollen counts 
affecting a larger spatial area. Sensitization is projected to increase in countries with an existing 
ragweed problem such as Romania and Italy, partly due to increased pollen production by 
established plant populations, but the greatest proportional increases is likely to be in areas 
where ragweed sensitization is currently relatively uncommon such as Germany, France and 
Poland. By 2041-2060, sensitization to ragweed will be widespread across the whole of Europe 
except for Scandinavia, the Baltic States, most of Spain, Portugal and Ireland. 
Table 1 also examines the impact of ragweed invasion scenario upon sensitization rates. Under 
the reference plant invasion scenario, the population sensitized to ragweed at the European level 
is estimated to increase from 33 million [27m – 38m] to 77 million [68m – 86m] by 2041-2060. 
In comparison, a slow plant invasion scenario reduces the projected future value to about 52 
million [44m - 59m], while a rapid plant invasion scenario increases the projected value to about 
107 million [98m - 117 m]. 
  
The sensitization rates presented in Table 1 were converted into estimates of clinically relevant 
sensitization rates using data from Burbach et al. (2009). These results are presented in Table S4, 
indicating that in comparison to the population sensitized to ragweed, the population clinically 
sensitized to ragweed in Europe is around 25% lower for both the baseline and 2041-2060. Table 
S4 also demonstrates that future changes in the European population base do not greatly affect 
our projections, but suggest lower impacts in countries such as Germany, Poland and Romania 
with a decreasing population, and accentuated impacts in countries with increasing populations 
(e.g. France, UK). 
To estimate the potential impacts of future climate-related changes on allergy symptoms for 
individuals sensitized to ragweed, maps of average total season pollen (Mid July – Mid October) 
subdivided into monthly periods were produced and are displayed in Figure 3. These estimates 
indicate that especially across France and NW Italy airborne pollen is likely to be present much 
earlier in the season (Mid July – Mid August) due to accelerated plant development. In the peak 
pollen months (Mid Aug – Mid September) more ragweed pollen is likely be present across 
Europe with the greatest increases occurring away from current pollen hotspots. Our projections 
suggest that pollen will persist in the air in the mid-September to mid-October period across 
most of Europe, likely due to delayed frosts (Storkey et al. 2014). 
Discussion 
 
It has been argued that climate change is likely to affect pollen-related allergy (Bielory et al. 
2012). To our knowledge, this is the first study to fully model the potential impacts of climate 
change on ragweed plant distribution, plant productivity, pollen production and dispersal, and the 
resulting impacts on pollen concentrations and allergic sensitization. 
  
We estimate that across Europe sensitization to ragweed is likely to more than double by 2041- 
2060 and that populations across most of Europe are likely to be affected. Our projections 
indicate that sensitization will continue to increase in countries with an existing ragweed 
problem, but the greatest proportional increases will be in areas where ragweed sensitization is 
currently relatively uncommon. Much of the projected change is due to the expected Northward 
expansion of ragweed, consistent with the expansion already observed in the US (Ziska et al. 
2011). Our estimates indicate that ragweed sensitized individuals may experience more severe 
symptoms due to higher ragweed pollen concentrations and a longer pollen season lasting into 
September and October across much of Europe. These projected changes are predominantly 
related to climate and associated land-use change (66%; Hamaoui-Laguel et al. 2015), but also 
include the dispersal of this alien plant through Europe even without climate change. 
One striking feature of the results is the large influence of plant invasion scenario. The reference 
plant invasion scenario uses the common assumption that the flux of seeds is inversely 
proportional to the square of the distance (Hamaoui-Laguel et al. 2015). The slow and rapid plant 
invasion scenarios were generated by altering the proportionality coefficient based upon the 
ranges reported in previous research (Richter et al. 2013). The slow plant invasion scenario 
assumes a limited expansion in the range of ragweed and more than halves the overall estimated 
increase in sensitization to ragweed projected by 2041-2060 under RCP4.5. It thus strongly 
suggests that control of ragweed is important for public health and as an adaptation strategy 
against the impacts of climate change. However, control of existing plants is difficult due to 
ragweed’s long-lived seeds, its ability to evolve herbicide resistance and its capacity to re-sprout 
following cutting (Brewer and Oliver 2009). Ragweed thrives on regular land disturbance, hence 
management of land is key to its control (Storkey et al. 2014). Controlling long distance seed 
  
dispersal is also important for preventing plant spread. This is predominantly associated with 
human activity and therefore controls over contaminated seed and monitoring areas prone to 
ragweed invasion are key elements to limit spread (Bullock 2010). 
We also examined the impact of different Representative Concentration Pathways (RCP 4.5 and 
8.5) and highlighted that these make little difference to the numbers of individuals sensitized to 
ragweed. This is likely to be due to saturation of the CO2 fertilization effect at higher 
concentrations but also the relatively similar climate between the two RCPs within the relatively 
short future timeframe of our analysis. Projected changes to the numbers and distribution of 
population across Europe have a relatively minor influence upon our results. 
This study emphasizes the multiple steps required to model the impact of climate change on 
pollen allergy. There are assumptions and uncertainties associated with each step of the process 
and as far as possible, we have been transparent about these and their impacts upon the results. 
We compared two regional climate model suites (WRF/RegCM, Chimere) that differ in 
atmospheric processing, pollen modelling and in the driving global climate model, and found 
responses in the same direction, although with substantial differences in magnitude. This 
highlights the need for multi-model approaches to the problem of future pollen simulation. Our 
research was strongly sensitive to the assumptions concerning plant invasion scenario, and this 
points to the importance of dispersal control (e.g. measures highlighted in Bullock 2010) as an 
effective tool to minimize ragweed allergy in the future. 
A notable element of uncertainty is the pollen/RSR dose-response relationship (adjusted R
2 
38.4%). This low value is a function of the limited number of studies reporting sensitization to 
ragweed and lack of standardization across studies. We have also assumed that the dose-response 
  
relationship between pollen and allergy is identical across Europe whereas differences in factors 
such as genetic pre-disposition may lead to a differential impact across the continent. 
In addition to climate change, plant invasion and population change, other factors may affect 
ragweed allergy into the future. By 2041-2060, levels of ozone air pollution across Europe are 
likely to decrease (Colette et al. 2012) potentially suppressing allergenicity of ragweed pollen 
(Pasqualini et al. 2011). Conversely, ragweed pollen allergenicity may be elevated through 
higher atmospheric CO2 levels and increasing drought (El Kelish et al. 2014; Singer et al. 2005). 
Inclusion of changing allergenicity is a priority for future research. By 2041-2060, the median 
age of the European population is projected to increase from 38 to 52 years (World Bank 2015) 
and ragweed allergy is more difficult to treat in aged populations due to greater difficulty in 
diagnosis and limited treatment options due to co-morbidities and ongoing medication use 
(Cardona et al. 2011). Appropriate management and use of medication can significantly improve 
allergy symptoms (Pawankar 2014). Such management can also be economically beneficial and 
appropriate therapy for allergic diseases and can be 5% of the cost of untreated disease 
(Zuberbier et al. 2014). Therefore, the overall impact of increasing ragweed allergy will be 
influenced by the adaptation capacities of individuals and healthcare systems across Europe. Ebi 
(2014) argues that the capacity of healthcare systems to adapt to climate change will depend 
upon the development pathways taken by individual countries. Pathways leading to increased 
inequalities and fragmentation in society present most challenges to adaptation (Ebi 2014), and 
hence to the potential problem of increasing ragweed allergy. 
Conclusions 
 
Our projections indicate that ragweed pollen allergy will become a common health problem 
across much of Europe, and that sensitization to ragweed will more than double, from 33 million 
  
currently to 77 million people by 2041-2060. According to our projections, sensitization will 
increase in countries with an existing ragweed problem (e.g. Hungary, the Balkans) but the 
greatest proportional increases are projected for countries where sensitization is now relatively 
uncommon (e.g. Germany, Poland, France). Our estimates also indicate that sensitized 
individuals may experience more severe symptoms as a consequence of higher ragweed pollen 
levels and an extended pollen season that will last into September and October across much of 
Europe. Our projections are primarily driven by assumptions regarding climate change (66%), 
but also reflect current trends in the spread of this invasive plant species across Europe. The 
projected health consequences are highly dependent upon the rate at which ragweed spreads, 
which is strongly related to control measures against the spread of this plant species (Bullock 
2010). This highlights that control of ragweed spread is essential for public health and as an 
adaptation strategy in response to climate change. 
To our knowledge this is the first study modelling the future impacts of climate change upon 
plant distribution, plant life cycles, pollen production and dispersal, and their subsequent impacts 
on pollen concentrations and allergy. Climate change consequences will not be restricted to 
ragweed and a recent review has highlighted a range of other pollen producing species that may 
be affected (Beggs 2015). Our methods provide a framework for other studies investigating the 
impacts of climate change upon pollen allergy for these other species. 
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Table 1: Current and future populations sensitized to ragweed pollen for three different 
plant invasion scenarios. Data are average of the CHIMERE and WRF/RegCM model 
suites for RCP4.5 [CHIMERE and WRF/RegCM values given in brackets]. 
 
 
 
Country 
Population sensitized in thousands [CHIMERE, WRF/RegCM values] 
Baseline  
Reference Ragweed 
Invasion Scenario 
2041-2060 
Slow Ragweed Invasion 
Scenario 
 
Rapid Ragweed Invasion 
Scenario 
Austria 890 [868,912] 1749 [1636,1863] 1354 [1282,1427] 2061 [1954,2169] 
Belgium 923 [732,1115] 2364 [2143,2585] 1616 [1452,1780] 2767 [2519,3015] 
Bulgaria 1150 [1135,1165] 1763 [1614,1912] 1442 [1350,1535] 2066 [1889,2243] 
Croatia 873 [804,943] 1098 [1041,1156] 1037 [973,1102] 1169 [1124,1214] 
Cyprus 7 [0,15] 36 [1,71] 15 [0,31] 77 [33,120] 
Czech Republic 487 [409,565] 1943 [1756,2130] 1150 [1054,1246] 2844 [2737,2950] 
Denmark 0 [0,0] 96 [29,163] 3 [0,7] 533 [426,640] 
Estonia 0 [0,0] 0 [0,0] 0 [0,0] 5 [3,7] 
Finland 0 [0,0] 0 [0,0] 0 [0,0] 0 [0,0] 
France 3233 [2256,4210] 10716 [8849,12582] 5989 [4480,7498] 15646 [14066,17225] 
Germany 4688 [2282,7095] 15689 [13337,18041] 9321 [6882,11759] 20928 [19129,22727] 
Greece 831 [487,1176] 1764 [1341,2188] 1284 [911,1658] 2320 [1908,2732] 
Hungary 2289 [2668,1910] 2899 [3069,2729] 2721 [2979,2464] 3006 [3098,2914] 
Ireland 0 [0,0] 4 [0,8] 0 [0,0] 82 [0,164] 
Italy 4786 [4097,5474] 10110 [9563,10656] 7480 [6846,8115] 13450 [13079,13821] 
Latvia 0 [0,0] 0 [0,0] 0 [0,0] 77 [78,75] 
Lithuania 0 [0,0] 6 [11,2] 0 [0,0] 224 [245,204] 
Luxembourg 15 [0,31] 78 [57,98] 33 [8,58] 124 [106,141] 
Malta 0 [0,0] 28 [18,38] 12 [5,19] 49 [38,60] 
Netherlands 2224 [1300,3148] 3489 [2863,4115] 2894 [2135,3654] 3862 [3374,4350] 
Poland 1123 [1251,994] 4397 [4175,4619] 2437 [2467,2408] 8733 [8382,9084] 
Portugal 0 [0,0] 0 [0,0] 0 [0,0] 356 [0,712] 
Romania 3097 [3045,3148] 4772 [4473,5072] 4016 [3796,4237] 5500 [5062,5938] 
Slovakia 626 [790,462] 1160 [1221,1100] 895 [1004,786] 1438 [1419,1457] 
Slovenia 304 [281,327] 424 [397,451] 385 [364,406] 470 [442,497] 
Spain 21 [0,42] 447 [35,858] 137 [1,272] 2670 [939,4401] 
Sweden 0 [0,0] 13 [1,25] 0 [0,0] 153 [114,192] 
United Kingdom 1196 [1008,1384] 6173 [5113,7232] 2631 [1988,3273] 10023 [9270,10776] 
Sum EU28 28764 [23413,34116] 71218 [62743,79693] 46855 [39975,53736] 100631 [91434,109828] 
Albania 394 [400,388] 626 [580,673] 513 [496,529] 784 [727,840] 
Andorra 0 [0,0] 2 [0,5] 0 [0,1] 9 [7,11] 
Bosnia & 
Herzegovina 
703 [682,724] 914 [869,958] 
 
855 
 
[819,890] 
 
980 
 
[937,1023] 
Iceland 0 [0,0] 0 [0,0] 0 [0,0] 0 [0,0] 
Kosovo 259 [196,323] 429 [391,468] 347 [287,407] 498 [492,504] 
Liechtenstein 1 [0,1] 3 [1,4] 1 [0,3] 4 [3,6] 
FYR Macedonia 300 [291,308] 486 [449,524] 395 [369,420] 584 [562,605] 
Montenegro 78 [56,101] 124 [101,146] 105 [81,129] 148 [131,164] 
Norway 0 [0,0] 0 [0,0] 0 [0,0] 4 [0,7] 
San Marino 2 [2,2] 5 [5,4] 4 [4,4] 6 [6,6] 
Serbia 1708 [1731,1685] 2073 [2042,2105] 1964 [1928,1999] 2140 [2129,2151] 
Switzerland 376 [135,618] 954 [650,1257] 650 [346,954] 1498 [1222,1774] 
Sum non-EU28 3822 [3493,4151] 5615 [5087,6144] 4833 [4331,5335] 6654 [6216,7091] 
Sum Europe 32586 [26905,38266] 76833 [67829,85837] 51688 [44305,59071] 107285 [97650,116919] 
  
 
Figure 1: The Relationship Between Ragweed Sensitization Rate (%) and Mean Pollen 
Level (Grains m
3
) adjusting for study population. Solid Line Represents Best Fit 
Relationship (logarithmic). 
Notes: 
a
3 locations excluded due to very low baseline pollen levels (< 10 grains m
3
y
-1
). 
Figure 2: Percentage of population sensitised to Ambrosia pollen; At baseline and in the 
Far Future; Averaged results for RegCM and CHIMERE; RCP4.5; Reference Invasion 
scenario. Data source: GISCO - Eurostat (European Commission). Administrative 
boundaries: © EuroGeographics © UN-FAO © Turkstat. 
 
Figure 3: Monthly current and future ragweed pollen counts (grains m
3
) across Europe. 
Data are average of the CHIMERE and WRF/RegCM model suites for RCP4.5 and a 
reference plant invasion scenario. Data source: GISCO - Eurostat (European Commission). 
Administrative boundaries: © EuroGeographics © UN-FAO © Turkstat. 
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